Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway

Abstract

Histone deacetylase inhibitors (HDACI) are promising anticancer agents and their use in combination with conventional anticancer drugs is currently under investigation. We previously reported cell line-specific upregulation of ABCG2, a multidrug resistance transporter shown to control oral bioavailability and CNS penetration, by the HDACI romidepsin, although the precise mechanism in a particular cell line remains to be determined. The aryl hydrocarbon receptor (AhR) is a ligand-dependent transcription factor that can be activated by numerous environmental contaminants and has been shown to be a client protein of heat shock protein 90 (Hsp90). A xenobiotic response element was defined in the ABCG2 promoter and was shown to mediate AhR signaling. Activated AhR was found to be associated with the ABCG2 promoter only in cell line models that respond to romidepsin with ABCG2 upregulation. Our data suggest that romidepsin acetylated Hsp70 and inhibited the chaperone function of Hsp90, thereby allowing the dissociation of AhR from Hsp90. The dissociation of AhR from Hsp90 may be a prerequisite for the differential upregulation of ABCG2 by romidepsin. Increasing our understanding of the mechanism(s) governing differential upregulation of ABCG2 in response to romidepsin could provide an insight into strategies needed to tackle resistance to HDACIs in cancer therapeutics. Mol Cancer Res; 9(4); 516-27. Ó2011 AACR.

Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport—an Update

“…To date, the cis regulatory elements identified in the BCRP promoter include an estrogen response element (ERE), a progesterone response element (PRE), a hypoxia response element (HRE), an antioxidant response element (ARE), an aryl hydrocarbon response element (AhRE), and the active nuclear factor kB subunit (NFkB) response element (2). Thus, the ABCG2 gene is upregulated under hypoxic conditions via the hypoxia-inducible factor 1α (HIF-1α) (171), by estradiol through estrogen receptor α (ERα) (178), by progesterone via progesterone receptor B (PRB) (179), and by aryl hydrocarbon receptor agonists through the aryl hydrocarbon receptor (AhR) (180). BCRP expression has also been shown to be induced via the peroxisome proliferators-activated receptor gamma (PPARγ) (181) or downregulated by dexamethasone possibly via glucocorticoid receptor (GR) (182).…”

AMPK-HDAC5 pathway facilitates nuclear accumulation of HIF-1α and functional activation of HIF-1 by deacetylating Hsp70 in the cytosol

“…These data suggest that HDAC5 facilitates HIF-1a transfer from the Hsp70 complex to the Hsp90 complex. Since all HIF-1a, Hsp90 and Hsp70 have been reported to be acetylated proteins, 42,[48][49][50][51] we next asked if HDAC5 deacetylates one or more of these proteins. HDAC5 knockdown did not significantly affect the total levels of Hsp90, Hsp70 or HIF-1a in the presence of MG132 (Fig.…”

The Role of Canalicular ABC Transporters in Cholestasis

“…CAR (phenobarbital, CITCO) and PXR (rifampicin and 2-acetylaminofluorene) ligands can thus increase ABCG2 expression in vitro (Jigorel et al, 2006;Lemmen et al, 2013). Other transcription factors can also induce ABCG2, and its promoter contains hypoxia, estrogen, progesterone, PPARg, and aryl hydrocarbon receptor response elements (Ebert et al, 2005;Szatmari et al, 2006;Robey et al, 2011;To et al, 2011). Cytokines, growth factors, and micro-RNAs affected gene expression in various ways, whereas promoter methylation increased ABCG2 expression in vitro (Le Vee et al, 2009;Robey et al, 2011).…”